Characteristic signs and symptoms |
Subclinical; can have mild malabsorption and be associated with growth faltering |
Chronic diarrhea, weight loss, manifestations of nutritional deficiencies |
A minority of patients have the classic diarrhea- predominant form; more patients have “silent” disease, characterized by lack of symptoms or extraintestinal symptoms, such as arthritis, infertility, anemia, and osteoporosis |
Perianal abscesses, intestinal fistulas, and strictures; individuals are at increased risk for PSC, ankylosing spondylsis, and psoriasis |
Histopathology |
Blunting of intestinal villi, increased crypt lengthening, intraepithelial lymphocytes and lymphocytic infiltration of the lamina propria |
Blunting of intestinal villi, increased crypt lengthening, increased mononuclear inflammatory cells and intraepithelial lymphocytes. |
*indistinguishable from EE |
Active and chronic inflammation, variable distortion to villous architecture, metaplastic epithelial changes, possible granulomas |
Serologic diagnosis |
No established biochemical parameters for diagnosis |
No established biochemical parameters for diagnosis |
Anti-tissue transglutaminse antibody; anti- endomysial antibody; anti- gliadin Ab (nonspecific) |
No established biochemical parameters for diagnosis |
Etiology |
Recurrent environmental exposure to fecal contamination |
Infectious |
Genetic predisposition with presence of HLA-DQ2 or HLA- DQ8 initiated by exposure to gluten proteins. Pathogenesis due to both t-cell and antibody- mediated response. |
Unknown; genetic predisposition to certain forms of the disease, involving NOD2 and autophagy gene (ATG161L). |
Available treatment |
None |
May respond to tetracycline therapy |
Avoidance of gluten in diet |
Corticosteroids and immunomodulating drugs |
Refs |
2 |
2,63
|
32, 80
|
64 |